Types of Dental Implants: Endosteal, Subperiosteal, and Beyond

Dental implant classification determines which surgical approach, hardware geometry, and osseointegration pathway a clinician selects — and those choices carry direct consequences for long-term outcomes. This page maps the principal implant types recognized in clinical literature and regulated device categories, explains the structural mechanics that distinguish them, and identifies where classification boundaries become contested. The scope covers endosteal and subperiosteal designs, zygomatic and pterygoid variants, and implant-loading protocols that represent distinct procedural categories rather than mere brand variations.

Definition and scope

A dental implant is a surgically placed device that substitutes for a natural tooth root and serves as a structural foundation for a prosthetic crown, bridge, or denture. The U.S. Food and Drug Administration regulates endosseous dental implants as Class II medical devices under 21 CFR Part 872, subject to 510(k) premarket notification requirements. Implant systems that represent novel technological characteristics may be elevated to Class III status, requiring Premarket Approval (PMA).

The clinical taxonomy of implant types is not arbitrary marketing segmentation — it reflects differences in anatomical placement zone, bone engagement strategy, load transfer mechanics, and the regulatory submission history of each device class. The FDA's Center for Devices and Radiological Health (CDRH) maintains product classification databases that clinicians and hospitals use to verify clearance status before procurement.

For a broader orientation to the regulatory landscape governing these devices, the regulatory context for dental implants provides detailed agency and standards framing.

Core mechanics or structure

Endosteal Implants

Endosteal ("within the bone") implants are the dominant design in modern practice. A titanium or zirconia fixture — most commonly a threaded screw with diameters ranging from approximately 3.0 mm to 6.0 mm — is surgically inserted directly into the alveolar or basal jawbone. Osseointegration, the direct structural and functional connection between living bone and the implant surface described by Per-Ingvar Brånemark's foundational research published between 1969 and 1985, anchors the fixture without fibrous tissue interposition.

Key structural subcomponents:
- Fixture (implant body): The portion embedded in bone; carries compressive and tensile loads.
- Abutment: The connector element that protrudes through the gingiva and receives the prosthetic crown.
- Prosthetic crown or superstructure: The visible tooth restoration seated on the abutment.

The dental implant components explained page details the geometry and material specifications of each sub-element.

Subperiosteal Implants

Subperiosteal implants rest on top of the jawbone, beneath the periosteum (the fibrous membrane covering bone). A custom metal framework — historically cast from cobalt-chromium, although titanium versions exist — is fabricated to conform to the patient's specific bone topography using impressions or CT-derived models. Posts protrude through the gingiva to support the prosthesis.

These devices do not rely on osseointegration; instead, retention depends on the periosteal tissue holding the framework against the bone surface. The American Academy of Implant Dentistry (AAID) notes that subperiosteal implants were more common before bone grafting techniques became reliable, and their use has diminished substantially since the 1980s.

Zygomatic Implants

Zygomatic implants anchor in the zygomatic bone (cheekbone) rather than the maxilla. At lengths commonly ranging from 30 mm to 52.5 mm, they are significantly longer than standard endosteal fixtures. Developed to address patients with severe maxillary bone atrophy who would otherwise require extensive bone grafting, zygomatic implants were initially described by Brånemark and colleagues in a 1998 publication in the International Journal of Oral and Maxillofacial Surgery.

Mini Dental Implants

Mini dental implants (MDIs) have diameters below 3.0 mm — typically between 1.8 mm and 2.9 mm. The FDA cleared a one-piece MDI system in 1997 under 510(k). Their primary clinical application is stabilization of mandibular dentures, though off-label use for full crown restorations is debated in the literature. The mini dental implants page covers their specific candidacy criteria.

Causal relationships or drivers

The type of implant selected is driven by three primary anatomical and physiological variables:

  1. Residual bone volume and density. Endosteal placement requires a minimum bone height — frequently cited in clinical guidelines as approximately 10 mm in the posterior mandible, though site-specific minimums vary — and adequate bone width. When bone volume is insufficient, either augmentation procedures or alternative implant types (zygomatic, subperiosteal) become the structural solution.

  2. Bone quality classification. The Lekholm and Zarb classification system (1985) grades jaw bone quality from Type I (dense cortical bone) through Type IV (thin cortical shell over sparse trabecular bone). Type IV bone in the posterior maxilla is associated with elevated implant failure rates in the literature, influencing fixture diameter and surface treatment selection.

  3. Loading timeline requirements. Patient need for immediate functional teeth drives selection toward immediate load dental implants protocols, which impose different fixture geometry and primary stability requirements than conventional two-stage healing.

The bone density requirements for dental implants resource elaborates on how imaging-derived bone assessments feed directly into implant type decisions.

Classification boundaries

The implant taxonomy becomes contested at several boundaries:

Endosteal vs. mini: The distinction is dimensional (diameter threshold) but regulatory submissions for MDIs have used the same 21 CFR 872.3640 product code as full-size endosteal devices, creating overlap in device classification databases.

Loading protocol as quasi-type: Immediate-load, early-load (provisional restoration placed 1–12 weeks post-surgery), and conventional-load (restoration after full osseointegration, typically 3–6 months) are sometimes discussed as implant "types" but are more precisely loading protocols applied to implants of any geometric type.

Implant-supported prosthesis systems: The All-on-4 dental implants and All-on-6 dental implants configurations describe prosthesis-to-implant ratios and angulation strategies, not distinct implant hardware types. The implant fixtures used are standard endosteal screws; the distinction lies in surgical placement planning and prosthetic architecture.

Zygomatic as endosteal variant: Zygomatic implants anchor in cortical bone and achieve osseointegration by the same mechanism as conventional endosteal devices. Some classification frameworks treat them as a subcategory of endosteal implants; others list them separately due to the anatomical site difference and distinct surgical technique requirements.

The how dental implants work page provides mechanistic grounding useful for understanding these boundary distinctions.

Tradeoffs and tensions

Design Primary Advantage Primary Limitation
Endosteal (standard) Long-term evidence base; modular prosthetic options Requires adequate bone volume; often needs grafting
Subperiosteal No bone height requirement for placement No osseointegration; limited long-term data post-1990s; custom fabrication cost
Zygomatic Avoids maxillary grafting; immediate loading possible Longer, more invasive surgery; sinus proximity risk
Mini (MDI) Less invasive; lower bone volume threshold Narrower evidence base for single-tooth applications; fracture risk under heavy occlusal load
Immediate-load protocol Patient receives functional teeth same day Requires high primary stability (insertion torque ≥ 35 Ncm in most protocols); higher risk if stability criteria unmet

The tension between bone grafting to enable standard endosteal implants versus using alternative designs (zygomatic, subperiosteal) involves weighing additional surgical stages, healing time, and graft material risks against the stronger long-term evidence base for endosteal osseointegrated fixtures. The bone grafting for dental implants page documents the augmentation pathway in detail.

Common misconceptions

Misconception: "All dental implants are titanium screws."
Correction: Zirconia (ceramic) endosteal implants received FDA 510(k) clearance and are used for patients with documented titanium sensitivity or aesthetic preferences in high-visibility zones. They differ from titanium in surface treatment capacity and fracture behavior under load.

Misconception: "Mini implants are just smaller versions of standard implants with equivalent applications."
Correction: The biomechanical load distribution across a 1.8 mm diameter fixture is fundamentally different from a 4.0 mm fixture. Clinical guidelines from the International Team for Implantology (ITI) distinguish their supported applications accordingly.

Misconception: "Subperiosteal implants are obsolete and no longer placed."
Correction: While rare, subperiosteal devices continue to receive placement in specific cases of extreme maxillary or mandibular atrophy where zygomatic options are contraindicated. The FDA device database still contains cleared subperiosteal implant products.

Misconception: "Implant type is the primary driver of success rates."
Correction: Published meta-analyses in journals such as the Journal of Dental Research consistently identify patient-level factors — smoking, uncontrolled diabetes, peri-implant hygiene — as significant predictors of failure, often outweighing implant design differences. See dental implants and smoking for documented risk data.

The comprehensive overview of implant topics available at dentalimplantsauthority.com provides additional context connecting implant type selection to candidacy and outcomes.

Checklist or steps

The following sequence represents the clinical decision pathway for implant type determination as described in evidence-based implant dentistry protocols (not a substitute for clinical evaluation):

Implant Type Determination — Clinical Decision Sequence

Reference table or matrix

Dental Implant Type Comparison Matrix

Implant Type Placement Zone Osseointegration Typical Diameter Primary Regulatory Reference Evidence Strength
Endosteal (root-form) Within alveolar/basal bone Yes 3.0–6.0 mm 21 CFR 872.3640 (Class II) Strongest; 40+ years clinical data
Subperiosteal On bone surface, under periosteum No N/A (custom framework) 21 CFR 872.3640 Limited post-1990; largely historical
Zygomatic Zygomatic bone (cheekbone) Yes ~4.0 mm body; 30–52.5 mm length 21 CFR 872.3640 (Class II/III by submission) Moderate; growing since 1998
Mini Dental Implant Within alveolar bone Yes 1.8–2.9 mm 21 CFR 872.3640 Moderate for denture stabilization; limited for single crowns
Immediate-load protocol Any endosteal site with adequate primary stability Yes (concurrent) Same as endosteal Not a device type; protocol per ITI/AO consensus Moderate-strong for anterior mandible; variable for posterior

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)